Canagliflozin: Who May Benefit From New Diabetes Drug?
Dr. Anne Peters discusses the clinical considerations in prescribing this first-in-class drug for type 2 diabetes. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - April 9, 2013 Category: Endocrinology Authors: Medscape Source Type: podcasts

Sevelamer: A Phosphate Binder Friend With Benefits?
Jeffrey Berns discusses the phosphate binder sevelamer and suggests that anti-inflammatory or antioxidant effects might be an added benefit for patients with kidney disease. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - April 1, 2013 Category: Endocrinology Authors: Medscape Source Type: podcasts

PCI vs CABG for Diabetes Patients: A Clear Winner
This F1000 commentary reports on a study whose findings support the superiority of CABG over PCI in diabetic patients with multivessel coronary artery disease. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - March 29, 2013 Category: Endocrinology Authors: Medscape Source Type: podcasts

Hypertension Drugs: Double Up Right Away?
Dr. Henry Black discusses a propensity analysis in a study on hypertension, in which patients who started on 2 drugs at the time of diagnosis did better than those who delayed combination therapy. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - March 15, 2013 Category: Endocrinology Authors: Medscape Source Type: podcasts

An Unusual Case of Type 1 Diabetes -- or Is It Type 2?
Dr. Anne Peters describes her management of a lean Asian man who came to her with a diagnosis of type 1 diabetes. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - March 7, 2013 Category: Endocrinology Authors: Medscape Source Type: podcasts

Key Changes in KDIGO CKD Guidelines
Jeffrey Berns talks about some highlights of the new KDIGO CKD guidelines, including staging and the end of microalbuminuria. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - March 4, 2013 Category: Endocrinology Authors: Medscape Source Type: podcasts

Kazano! New Alogliptin Combos for Type 2 Diabetes
Dr. Anne Peters explains prescribing considerations for the newly approved alogliptin and its combination formulations. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - February 13, 2013 Category: Endocrinology Authors: Medscape Source Type: podcasts

What's New in ADA's Latest Diabetes Guidelines?
Dr. Anne Peters discusses the changes to the standards of care updated annually by the American Diabetes Association. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - February 7, 2013 Category: Endocrinology Authors: Medscape Source Type: podcasts

eGFR: Remember, 'e' Stands for 'Estimated'
Jeffrey Berns discusses the challenge of staging chronic kidney disease on the basis of a single GFR value and why you should remember that it is an estimate only. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - January 29, 2013 Category: Endocrinology Authors: Medscape Source Type: podcasts

CGM: Practical Uses in Diabetes
Dr. Anne Peters discusses the real-life use of continuous glucose monitoring and recent advances in the technology. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - January 25, 2013 Category: Endocrinology Authors: Medscape Source Type: podcasts